A Phase 2B Randomized Double-Blind Placebo-Controlled Multiple Dose Multicenter Study to Assess Efficacy and Safety of SER 287 in Adults with Active Mild-to-Moderate Ulcerative Colitis
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
